Keyphrases
Dyskeratosis Congenita
100%
Cellular Impacts
100%
X-linked Dyskeratosis Congenita
100%
H/ACA Ribonucleoprotein
41%
X-linked
41%
SHQ1
33%
Cajal Body
33%
Terra
25%
RNAome
16%
Patient Cells
16%
RNA Splicing
8%
Non-coding RNA (ncRNA)
8%
Negative Stain Electron Microscopy
8%
Micron-sized
8%
Healthy Carriers
8%
Chaperone
8%
Model Cell
8%
Molecular Mechanism
8%
Protein Synthesis Regulation
8%
Ribonucleoprotein Biogenesis
8%
Telomere Maintenance
8%
Ribonucleoprotein
8%
Specific Antibodies
8%
Dyskerin
8%
Prostate
8%
Knockdown
8%
Ribosome Biogenesis
8%
Telomere
8%
Disease Phenotype
8%
Biological Approach
8%
Next-generation Sequencing
8%
Specific Intent
8%
Relative Abundance
8%
Nucleolus
8%
Inherited Bone Marrow Failure Syndromes
8%
Cas9 Protein
8%
Nuclear Bodies
8%
Therapeutic Approaches
8%
Nopp140
8%
Molecular Impact
8%
Stable Expression
8%
Cryogenic Electron Microscopy
8%
Nucleolar
8%
Cellular Processes
8%
Biochemistry, Genetics and Molecular Biology
Dyskeratosis Congenita
100%
RNA
61%
Ribonucleoprotein
46%
Cajal Body
30%
Wild Type
23%
Telomerase
23%
Stable Expression
7%
Bone Marrow Failure
7%
Electron Microscopy
7%
RNA Splicing
7%
Protein Biosynthesis
7%
Downregulation
7%
Maturation
7%
Nucleolus
7%
Ribosome Biogenesis
7%
Dyskerin
7%
Telomere Homeostasis
7%
Non-Coding RNA
7%
CRISPR
7%
Biogenesis
7%
Next Generation Sequencing
7%
Cryoelectron Microscopy
7%
Telomere
7%
Deficiency
7%